Related Experiment Video
Updated: Jun 5, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Topical issues in venous thromboembolism
José Ignacio Abad Rico1, Juan Vicente Llau Pitarch, José Antonio Páramo Fernández
1Trauma and Orthopaedic Surgery Department, Carlos Haya Regional University Hospital, Malaga, Spain.
Venous thromboembolism (VTE) management faces challenges due to anticoagulant limitations and underused prophylaxis. Optimizing treatment strategies and adherence is crucial for improving patient outcomes in VTE prevention.
Area of Science:
- Medical Science
- Pharmacology
- Clinical Medicine
Background:
- Venous thromboembolism (VTE) remains a significant clinical challenge, particularly in hospitalized patients, despite established treatment guidelines.
- Current anticoagulant therapies present limitations, including bleeding risks and monitoring requirements, necessitating a review of existing treatments and guidelines.
- Underutilization of VTE prophylaxis, especially in medical patients, highlights a gap between guidelines and clinical practice.
Purpose of the Study:
- To review current topical issues in venous thromboembolism (VTE) management, focusing on treatments, available data, and clinical guidelines.
- To discuss the limitations of existing anticoagulant therapies and the challenges in VTE prevention and treatment.
- To explore strategies for improving the administration and duration of thromboprophylaxis.
Main Methods:
- Review of existing literature on VTE treatments, including vitamin K antagonists, unfractionated heparin (UFH), low molecular weight heparins (LMWH), and fondaparinux.
- Analysis of current guidelines and data regarding thromboprophylaxis, particularly in surgical and medical patients.
- Discussion of challenges such as variable definitions, conflicting guidelines, and limited data in specific populations (e.g., children).
Main Results:
- Existing anticoagulants like vitamin K antagonists and UFH have limitations including monitoring needs and administration challenges.
- Low molecular weight heparins (LMWH) and fondaparinux offer advantages such as predictable pharmacokinetics and reduced monitoring.
- Thromboprophylaxis is underused, and optimal timing ('just-in-time' strategy) versus bleeding risk remains a key consideration, especially post-orthopaedic surgery.
Conclusions:
- Improving VTE management requires addressing anticoagulant limitations, optimizing thromboprophylaxis strategies, and enhancing adherence to guidelines.
- Strategies such as wider administration of prophylaxis, 'just-in-time' protocols, adequate duration, combination therapies, and new anticoagulant development are recommended.
- Standardizing definitions and addressing data gaps in clinical trials are essential for clearer VTE prevention and management.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management

